ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,651Medicare Part D Prescriptions Filled, Including Refills

Rank: 224 out of 939

$837K Total Retail Price of All Prescriptions

Rank: 81 out of 939

315 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 315 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 315 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 4,229 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 379 124 S3 1 1
OXYCODONE HCL 286 39 S2 2 67
FUROSEMIDE 278 131 3 7
GABAPENTIN 272 66 4 11
LEVOTHYROXINE SODIUM 262 161 5 4
OMEPRAZOLE 254 110 6 5
CARVEDILOL 211 106 7 25
POTASSIUM CHLORIDE 187 96 8 9
LISINOPRIL 168 84 9 3
LYRICA 162 28 10 63
TRAMADOL HCL 159 87 11 16
NEXIUM 152 53 12 18
SIMVASTATIN 143 74 13 2
MELOXICAM 142 73 14 14
METFORMIN HCL 142 81 14 8
RANITIDINE HCL 140 59 16 35
CYMBALTA 128 29 17 44
CARISOPRODOL 128 33 R 17 51
PROMETHAZINE HCL 116 19 R 19 68
RAMIPRIL 112 51 20 91
ATORVASTATIN CALCIUM 106 38 21 22
AMLODIPINE BESYLATE 105 61 22 6
PROAIR HFA 104 41 23 41
ZOLPIDEM TARTRATE 100 55 24 20
CITALOPRAM HBR 95 30 25 15
TRAZODONE HCL 93 27 26 26
MIRTAZAPINE 90 53 27 56
ESTRADIOL 89 0 R 28 79
TAMSULOSIN HCL 87 58 29 27
METOPROLOL TARTRATE 83 39 30 10
PRAVASTATIN SODIUM 80 46 31 13
TOPIRAMATE 80 0 31 154
TIZANIDINE HCL 79 0 33 81
FENOFIBRATE 77 34 34 83
SINGULAIR 72 46 35 101
MORPHINE SULFATE ER 72 0 S2 35 113
SPIRIVA 69 24 37 73
CYCLOBENZAPRINE HCL 68 15 R 38 36
BUPROPION XL 67 11 39 179
OXYCODONE HCL-ACETAMINOPHEN 66 25 S2 40 107
CLOPIDOGREL 58 40 41 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 13 41 64
HYDROCHLOROTHIAZIDE 57 36 43 12
LOVAZA 57 30 43 191
ROPINIROLE HCL 56 35 45 78
ESCITALOPRAM OXALATE 56 34 45 61
OXYCONTIN 55 0 S2 47 161
CLONIDINE HCL 55 29 47 39
DOXYCYCLINE HYCLATE 54 27 49 84
ALLOPURINOL 54 23 49 31
CELEBREX 53 34 51 106
HYDROXYZINE HCL 53 24 R 51 206
SERTRALINE HCL 53 24 51 24
PAROXETINE HCL 53 27 51 70
ISOSORBIDE MONONITRATE ER 51 33 55 53
METHOCARBAMOL 50 0 R 56 149
ABILIFY 50 0 56 156
TRICOR 50 31 56 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.